-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The main purpose of the study was to evaluate the safety and tolerance of Chinese health subjects after a single dose of off-the-cortective injection or intravenous injection of IBI112.
secondary purpose was to evaluate the characteristics and immunogenicity of post-drug pharmacological dynamics (PK) of IBI112 in a single dose of subderfic injection or intravenous giving to healthy subjects in China.
purpose of the study was to evaluate the post-IBI112 pharmacodynamic (PD) characteristics of single-dose subderfect injections or intravenous giving to healthy subjects in China.
IBI112 is an IL-23 monoantigen, IL-23 is a new type of isogenic cytokine consisting of IL-12/IL-23p40 and specific IL-23p19 sub-base.
-23 play an important role in autoimmune diseases, rheumatoid arthritis and inflammatory bowel diseases and infections.
.